Description
Specifications
| Form | Lyophilized powder, single vial |
| Sizes | 10 mg, 20 mg |
| Sequence | GEPPPGKPADDAGLV |
| Made in | USA |
| Testing | Third-party identity and purity, every lot |
| BPC-157 | C₆₂H₉₈N₁₆O₂₂ · MW 1419.5 · CAS 137525-51-0 |
How Is BPC-157 Studied?
BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of body protection compound, a protein first isolated from gastric juice. Studies have examined its cytoprotective and angiogenic effects, including nitric oxide signaling and growth factor pathways such as VEGFR2. Preclinical models have investigated its effects on tissue repair across gut, tendon, ligament and muscle, making it a common research tool for studying regenerative signaling.
Storage
Store the sealed vial at −20 °C for long-term storage, or 2–8 °C short-term, away from light. Once reconstituted in the lab, keep at 2–8 °C and avoid repeated freeze-thaw cycles.
FAQ
Do you carry BPC-157 in blends?
Yes. See the BPC-157 / TB-500 blend, the GLOW and KLOW blends, and the BPC-157 / KPV / Larazotide capsules.
Is a Certificate of Analysis available?
Yes. Tap “View Certificate of Analysis” on this page for the current lot’s third-party COA.
Do you provide use or dosing guidance?
No. This product is sold strictly for laboratory research, and orders indicating human or animal use are cancelled.
For laboratory research use only. Not for human consumption.
